Please Explain podcast: Are we close to securing a COVID-19 vaccine?
Save articles for later
Add articles to your saved list and come back to them any time.
The government has invested in two more projects seeking a coronavirus vaccine, to secure another 50 million doses. Last week it announced deals with Novavax and Pfizer/BioNTech, in addition to agreements already in place for the University of Oxford and University of Queensland vaccines.
Pfizer/BioNTech’s coronavirus vaccine trials have been welcomed by experts, prompting renewed calls for Australia to invest in new types of vaccine manufacturing technology.
This week an interim analysis of the vaccine’s phase three study was announced. The companies found it was more than 90 per cent effective in protecting participants.
In this episode, senior journalist Jacqueline Maley is joined by healthcare reporter Emma Koehn to discuss Australia's investment in coronavirus vaccines and mRNA technology.
Our supporters power our newsrooms and are critical for the sustainability of news coverage.
Becoming a subscriber also gets you exclusive behind-the-scenes content and invitations to special events. Click on the links to subscribe to The Sydney Morning Herald or The Age.
Sign up to our Coronavirus Update newsletter
Get our Coronavirus Update newsletter for the day’s crucial developments at a glance, the numbers you need to know and what our readers are saying. Sign up to The Sydney Morning Herald’s newsletter here and The Age’s here.
Most Viewed in National
Source: Read Full Article